Russia miffed at Teva over halt in Copaxone supply

Russia's Federal Antimonopoly Service: Teva's refusal to supply Copaxone is neither justified economically nor technologically.

By SHIRI HABIB-VALDHORN, ILANIT HAYUT
October 16, 2013 22:45
Teva Pharmaceutical plant is seen in Jerusalem

Teva 311. (photo credit: REUTERS/Ronen Zvulun)

1


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS